DM
DiBiase Mary
Chief Operating Officer
OtherF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by DiBiase Mary, Chief Operating Officer. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 21 filings have been recorded. Split: 0 buy · 15 sells. Total volume traded: €90k. History available since 8 September 2021. The latest transaction was disclosed on 12 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to DiBiase Mary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
650,000 shares0Common StockSEC:0001628280-25-005696:0
61,178 shares0Common StockSEC:0001628280-25-002706:0
230,645 shares0Common StockSEC:0001628280-24-042542:0
2,642 shares@ US$0.65771.8% of flowCommon StockSEC:0001628280-24-040128:0
15,409 shares@ US$0.88213.9% of flowCommon StockSEC:0001628280-24-010278:0
3,683 shares@ US$1.0073.8% of flowCommon StockSEC:0001628280-24-004288:0
67,695 shares@ US$0.7352.2% of flowCommon StockSEC:0001628280-23-036757:0
230,645 shares0Common StockSEC:0001628280-23-036459:0
2,642 shares@ US$1.2493.4% of flowCommon StockSEC:0001628280-23-032065:0
464 shares@ US$1.890.9% of flowCommon StockSEC:0001628280-23-024229:0
857 shares@ US$1.931.7% of flowCommon StockSEC:0001628280-23-023445:0
857 shares@ US$2.232.0% of flowCommon StockSEC:0001628280-23-022480:0
18,192 shares@ US$0.8416.1% of flowCommon StockSEC:0001628280-23-007724:0
4,348 shares@ US$0.934.2% of flowCommon StockSEC:0001628280-23-003758:0
1,713 sharesCommon StockSEC:0001628280-22-023325:0
1,578 sharesCommon StockSEC:0001628280-22-018397:0
856 sharesCommon StockSEC:0001628280-22-018044:0
856 sharesCommon StockSEC:0001628280-22-017435:0
105,000 shares0Common StockSEC:0001628280-22-004518:0
12,545 sharesCommon StockSEC:0001628280-22-002508:0
27,000 shares0Common StockSEC:0001628280-21-018385:0
About DiBiase Mary
DiBiase Mary is Directeur des Opérations at X4 Pharmaceuticals, Inc (XNAS). The record shows 21 filings in total, and within the recent sampled filings, all are sales, with 0 EUR of buys and 89512 EUR of sales between 2021-09-10 and 2025-02-14.